US Diabetes Care Market Size & Trend Analysis | 2025-2031
The U.S. diabetes monitoring, treatment and drug delivery market was valued at nearly $48 billion in 2024 and is expected to grow to $79 billion by 2031.| iData Research
The U.S. diabetes monitoring, treatment and drug delivery market was valued at nearly $48 billion in 2024 and is expected to grow to $79 billion by 2031.| iData Research
US FDA approved Novo Nordisk to use their GLP-1 drug, Ozempic, to reduce the risk of kidney failure and kidney disease progression.| iData Research
iData Research empowers you to make intelligent data-driven decisions based on comprehensive and detailed healthcare market research and consulting.| iData Research
Discover the top robotic surgery companies and advancements in the field. Learn how these systems are revolutionizing the way surgeries are performed.| iData Research
Discover the top 5 diabetes drugs in 2025, including GLP-1 receptor agonists, once-weekly insulin, and SGLT2 inhibitors.| iData Research
The U.S. diabetes market is rapidly evolving, driven by tech innovation, rising obesity rates, and growing demand for personalized treatment solutions.| iData Research
iData Research’s Robotic Surgery Growth insights reveal a market undergoing rapid transformation. The surgical robotics market is accelerating worldwide, with| iData Research
Overall, the U.S. surgical navigation and robotics market was valued at nearly $7 billion in 2023. This is expected to increase at a CAGR of 15.4% over the forecast period, reaching nearly $18.9 billion in 2030.| iData Research
Surgical robotics is transforming healthcare with AI, precision, and automation, making robotic-assisted surgery more accessible and effective worldwide.| iData Research
Robotic surgery is revolutionizing minimally invasive procedures, driving precision, faster recovery, and global adoption.| iData Research
The continuous glucose monitoring market has experienced strong but slowing growth in the U.S. blood glucose monitoring sector.| idataresearch.com
